BIXTOTCPharmaceutical PreparationsFiscal year ends December 31
BIOXYTRAN, INC
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$0.02−0.00 (-3.95%)
Close on Oct 19, 2026
- Market cap
- $2.56M
- P/E (TTM)
- –
- Dividend yield
- –
Price history
Daily open, high, low, close and volume
| Date | Open | High | Low | Close | Change | Volume |
|---|---|---|---|---|---|---|
| Daily prices are not in StockData yet. This table fills in once an end-of-day price source is connected. | ||||||
Stock splits
From SEC filings
| Date | Ratio | Effect on per-share figures |
|---|---|---|
| Aug 22, 2018 | 1-for-30 reverse | Earlier per-share figures multiplied by 30 |
| Apr 10, 2015(first seen in filings) | 1-for-50 reverse | Earlier per-share figures multiplied by 50 |
| Mar 9, 2015 | 1-for-50 reverse | Earlier per-share figures multiplied by 50 |
| May 2, 2011 | 3-for-1 | Earlier per-share figures divided by 3 |